🇺🇸 FDA
Patent

US 12383566

Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity

granted A61KA61K31/05A61K31/245

Quick answer

US patent 12383566 (Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity) held by Northwestern University expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/05, A61K31/245, A61K31/4174, A61K31/55